Top

Published in:

Open Access 01-06-2007 | Perspectives

Consumer Directed Healthcare: Except for the Healthy and Wealthy It’s Unwise

Authors: Steffie Woolhandler, MD, MPH, David U. Himmelstein, MD

Published in: Journal of General Internal Medicine | Issue 6/2007

Abstract

Many politicians and business leaders are advocating high deductible health insurance plans linked with health savings accounts—so-called consumer-directed healthcare. These policies penalize the sick, discourage needed care (especially primary and preventive care), and direct tax subsidies towards the wealthiest Americans. They offer little hope of slowing the growth of health care costs and add further bureaucratic costs and complexity to our health care financing system.

Newhouse JP, Insurance Experiment Group. Free For All? Lessons from the Rand Health Insurance Experiment. Cambridge, MA: Harvard University Press; 1993.

Freudenheim M. Prognosis is mixed for health savings; though enrollment grows, many don’t bother to save. New York Times, January 26, 2006:C1.

Agency for Healthcare Research and Quality. MEPS HC-079: 2003 Full Year Consolidated Data File. Available at http://www.meps.ahrq.gov/mepsweb/data_stats/download_data_files_details.jsp?cboPufNumber=HC-079. Accessed March 26, 2007.

Office of the Actuary, Centers for Medicare & Medicaid Services. National Health Care Expenditures Projections: 2004–2014. Table 5. Available at http://www.cms.hhs.gov/NationalHealthExpendData/downloads/nheprojections2004-2014.pdf. Accessed February 8, 2006.

United States Government Accountability Office. Federal Employees Health Benefits Program: Early Experience with Consumer-directed Health Plans. Washington, DC: November, 2005. GAO-06-143. Available at http://www.gao.gov/new.items/d06143.pdf. Accessed February 14, 2006.

Wal-Mart Stores, Inc. Supplemental Benefits Documentation: Board of Directors Retreat FY06 Wal-Mart Stores, Inc. Available at http://www.nytimes.com/packages/pdf/business/26walmart.pdf. Accessed February 14, 2006.

Tax Policy Center. Effective Marginal Federal Income Tax Rates for a Head of Household with One Child in 2005. Available at http://www.taxpolicycenter.org/TaxFacts/TFDB/Content/Excel/effective_marginal_2005.xls. Accessed March 26, 2007.

Conference Board of Canada. Challenging Health Care System Sustainability, Understanding Health System Performance of Leading Countries (2004). Available at http://www.conferenceboard.ca/boardwiseii/signin.asp. Accessed November 26, 2006.

Enterline PE, Salter V, McDonald AD, McDonald JC. The distribution of medical services before and after “free” medical care—the Quebec experience. N Engl J Med. 1973;289(22):1174–8.PubMedCrossRef

10.

Beck RG, Horne JM. Utilization of publicly insured health services in Saskatchewan before, during and after copayment. Med Care. 1980;18(8):787–806.PubMedCrossRef

11.

Tamblyn R, Laprise R, Hanley JA, et al. Adverse events associated with prescription drug cost—sharing among poor and elderly persons. JAMA. 2001;285(4):421–9.PubMedCrossRef

12.

Becker C. One question: credit or debit? As health savings accounts gain in popularity, insurers and the financial services industry want to bank the cash. Mod Healthc. 2006;36:6–16.

13.

Romano M. Driven to distress. Mod Healthc. 2006;36:28–30.PubMed

Title: Consumer Directed Healthcare: Except for the Healthy and Wealthy It’s Unwise
Authors: Steffie Woolhandler, MD, MPH
David U. Himmelstein, MD
Publication date: 01-06-2007
Publisher: Springer-Verlag
Published in: Journal of General Internal Medicine / Issue 6/2007
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI: https://doi.org/10.1007/s11606-007-0187-3

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2007

Implementing Routine Cognitive Screening of Older Adults in Primary Care: Process and Impact on Physician Behavior

Awareness of Hepatitis C Diagnosis is Associated with Less Alcohol Use Among Persons Co-Infected with HIV

Decreased Awareness of Current Smoking Among Health Care Providers of HIV-positive Compared to HIV-negative Veterans

Association Between Length of Residence and Cardiovascular Disease Risk Factors Among an Ethnically Diverse Group of United States Immigrants

A Captive Audience: A Pilot Study of Screening and Counseling Hospitalized Women for Fracture Risk

Visits for Depression by Elderly Patients

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials